Media coverage
18
Media coverage
Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Business Wire Country/Territory United States Date 18/6/3 URL www.businesswire.com/news/home/20180603005046/en/ASCO-2018-GenoscoYuhan-Announce-Results-Phase-12 Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Morningstar.com Country/Territory United States Date 18/6/3 URL news.morningstar.com/all/business-wire/BWIPREM20180603005046/asco-2018-genoscoyuhan-announce-results-from-phase-12-study-of-lazertinib-yh25448-gns-1480-a-3rd-generation-egfr-tki-in-advanced-nsclc.aspx Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet 4 Traders Country/Territory United States Date 18/6/3 URL www.4-traders.com/news/ASCO-2018-Genosco-Yuhan-Announce-Results-from-Phase-1-2-Study-of-Lazertinib-YH25448-GNS-1480-a--26705453/?utm_medium=RSS&utm_content=20180603 Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Maryville Daily Times Country/Territory United States Date 18/6/3 URL https://www.thedailytimes.com/business/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_715a35f5-87cb-5c01-8cfd-36a58e894953.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Spoke.com Country/Territory United States Date 18/6/3 URL www.spoke.com/press_releases/5b13fc822c33d47ab8011e85 Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Pharmacy Choice Country/Territory United States Date 18/6/3 URL www.pharmacychoice.com/news/article.cfm?Article_ID=2022614 Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet CIT Country/Territory United States Date 18/6/3 URL www.businesswire.com/news/home/20180603005046/en/ASCO-2018-GenoscoYuhan-Announce-Results-Phase-12 Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet SC Now Country/Territory United States Date 18/6/3 URL www.scnow.com/news/business/wire/article_cce2cf73-b955-5f40-aa84-ca3060bad674.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Bristol Herald Courier Country/Territory United States Date 18/6/3 URL www.heraldcourier.com/news/business_ap/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_3acf4af7-fed7-56af-ae49-e639a36f148a.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Daily American Country/Territory United States Date 18/6/3 URL https://www.dailyamerican.com/news/business/nation/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_d305ced1-3a3d-5435-9e25-9d39c6f8b8d2.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Press of Atlantic City Country/Territory United States Date 18/6/3 URL www.pressofatlanticcity.com/business/technology/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_c8d93b3f-9db6-5232-9c0c-0aebfa1b1272.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 18/6/3 URL www.valdostadailytimes.com/news/business/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_82f84abc-5089-5ec7-97a8-fbfce57cd304.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Clarksburg Exponent Telegram Country/Territory United States Date 18/6/3 URL https://www.wvnews.com/newsfeed/business/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_2e07d157-6bbf-5bbc-827c-5b282145eb4f.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Scottsbluff Star-Herald Country/Territory United States Date 18/6/3 URL www.starherald.com/news/nation_world/asco-genosco-yuhan-announce-results-from-phase-study-of-lazertinib/article_e1204663-5176-5217-a80f-277e5baced76.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Maryville Daily Forum Country/Territory United States Date 18/6/3 URL www.maryvilledailyforum.com/news/state_news/article_300b5a6a-4e4c-5d00-9c87-f4cd84dd515b.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Galveston County Daily News Country/Territory United States Date 18/6/3 URL www.galvnews.com/news_ap/business/article_49039205-2e04-51a5-a409-b0aaae4df6b1.html Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet KOLD-TV Country/Territory United States Date 18/6/3 URL www.tucsonnewsnow.com/story/38335441/asco-2018-genoscoyuhan-announce-results-from-phase-12-study-of-lazertinib-yh25448-gns-1480-a-3rd-generation-egfr-tki-in-advanced-nsclc Persons Hee Seung Lee Title ASCO 2018: Genosco/Yuhan Announce Results from Phase 1/2 Study of Lazertinib (YH25448, GNS-1480), a 3rd-Generation EGFR-TKI, in Advanced NSCLC Media name/outlet Venture Beat Profiles Country/Territory United States Date 18/6/3 URL https://www.vbprofiles.com/press_releases/5b13fe8e9490494786f5de30 Persons Hee Seung Lee